Interaction between cigarette smoke and mycoplasma infection: A murine model

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 3, Issue 1, 2006, Pages 3-8

  Martin, Richard J ^a,c   Wexler, Rachel B ^a   Day, Brian J ^a   Harbeck, Ronald J ^a   Pinkerton, Kent E ^b   Chu, Hong Wei ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Cigarette smoke; COPD; Infection; Mouse model; Mycoplasma

Indexed keywords

CIGARETTE SMOKE; ELASTIN; GELATINASE B; MESSENGER RNA; SODIUM CHLORIDE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CIGARETTE SMOKING; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; GENE EXPRESSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS; LUNG PARENCHYMA; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING; SMOOTH MUSCLE; TISSUE LEVEL; TISSUE STRUCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LUNG VOLUME MEASUREMENTS; MICE; MICE, INBRED BALB C; MYCOPLASMA INFECTIONS; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 33745033606     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550500493162     Document Type: Article

References (35)

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4:1241-1243.
2. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22(4):672-688.
3. The National Awareness Panel. Guidelines for the early detection and management of COPD. J Respir Dis 2000; 21(Suppl. 9):5-21.
4. Pietila MP, Thomas CF. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease. Semin Respir Infect 2003; 18:9-16.
5. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schacter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148(7)727-732.
6. Hahn DL, Bukstein D, Luskin A, Zeitz H. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 1998; 80(1):45-49.
7. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266(2):225-230.
8. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993; 70(1):23-25.
9. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 1994; 149(5):1348-1353.
10. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998; 158(3):998-1001.
11. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107(4):595-601.
12. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002; 121(6):1782-1788.
13. Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000; 106(4)713-722.
14. Von Hertzen L, Alakarppa H, Koskinen R, Liippo K, Surcel HM, Leinonen M, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997; 118(2):155-164.
15. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24(5):577-582.
16. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003; 71(3):1520-1526.
17. Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, Jenkins RA, et al. A sidestream cigarette smoking generator and exposure system for environmental tobacco smoke studies. J Inhal Toxicol 1994; 6:79-93.
18. Smith KR, Uyeminami DL, Kodavanti UP, Crapo JD, Chang LY, Pinkerton KE. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 2002; 33(8):1106-1114.
19. Takubo Y, Guerassimov A, Ghezzo H, Triantafillopoulos A, Bates JH, Hoidal JR, et al. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. Am J Respir Crit Care Med 2002; 166(12 Pt 1):1596-1603.
20. Elliot JG, Carroll NG, James AL, Robinson PJ. Airway alveolar attachment points and exposure to cigarette smoke in utero. Am J Respir Crit Care Med 2003; 167(1):45-49.
21. Howard CV, Reed MG. Unbiased sterology: three-dimensional measurement in microscopy. New York: Springer Verlag; 1998.
22. Wenzel SE, Trudeau JB, Barnes S, Zhou X, Cundall M, Westcott JY, et al. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 2002;169(8):4613-4619.
23. Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder RM, Voelkel NF. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167(11):1516-1521.
24. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(5 Pt 1):1635-1639.
25. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999; 20(6):1100-1102.
26. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156(1):240-247.
27. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999;159(6):1985-1991.
28. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78(9):1077-1087.
29. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26(5):602-609.
30. Elliott WM, Hayashi S, Hogg JC. Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995; 12(6):642-648.
31. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146(1):177-184.
32. Cherry JD, Taylor-Robinson D, Willers H, Stenhouse AC. A search for mycoplasma infections in patients with chronic bronchitis. Thorax 1971;26(1):62-67.
33. Clementsen P, Farholt S, Permin H, Lange P, Stahl Skov P, Norn S. Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls. Inflamm Res 2000; 49 Suppl 1:S37-38.
34. Theegarten D, Mogileuski G, Anhenn O, Stamatis G, Jaeschock R, Morgenroth K. The role of chlamydia in the pathogenesis of pulmonary emphysema. Virchows Arch 2000; 437:190-193.
35. Lambert HP. Antibody to Mycoplasma pneumoniae in normal subjects and in patients with chronic bronchitis. J Hyg Camb 1968; 66:185-189.